Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 40 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Prachi V.

Canada

USD 40 /hr

Scientific Editor | Medical Writer | Scientist- Preclinical Drug Development, Innate Immunity, Alzheimer's Disease

Profile Summary

Freelance Scientific Editor and Medical Writer with experience in clinical trial documentation. Academic research in the fields of drug development, inflammation and innate immune response. Long-term experience in teaching and slide deck preparation. Experience in creating RFPs as per client needs.

Subject Matter Expertise

• ★ Neuropharmacology
• ★ Preclinical Research
• ★ Inflammation
• ☆ Immunoassay
• ☆ Neuroscience
• ☆ Psychiatry
• ☆ Psychopharmacology

Services

• Writing
• Research
• Data & AI

Writing Medical Writing, Technical Writing, General Proofreading & Editing

Research Market Research, Gap Analysis, Gray Literature Search, Systematic Literature Review

Data & AI Statistical Analysis

Work Experience

Postdoctoral Research fellow

University Health Network, Toronto, Canada

October 2014 - October 2017

Education

Ph.D. Pharmaceutical Science

University of Oklahoma Health Sciences Center

September 2007 - June 2012

Certifications

• Applied Clinical Research certificate

  McMaster University

  May 2019 - Present

Publications

JOURNAL ARTICLE

Zhiyu Wang, Vilekar P, Huang J, Donald Weaver (2020). Furosemide as a Probe Molecule for the Treatment of Neuroinflammation in Alzheimer's Disease . ACS chemical neuroscience.

Wang Z, Wang Y, Vilekar P, Yang SP, Mayuri Gupta, Oh MI, Autumn Meek, Doyle L, LAURA VILLAR, Brennecke A, et al. (2020). Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide . PeerJ.

Awasthi V, Vilekar P, Rao G, Awasthi S (2019). Anti-inflammatory mediators ST2 and SIGIRR are induced by diphenyldifluoroketone EF24 in lipopolysaccharide-stimulated dendritic cells . Immunobiology.

Awasthi S, Vilekar P, Conkleton A, Rahman N (2019). Dendritic cell-based immunization induces Coccidioides Ag2/PRA-specific immune response . Vaccine.

Liyanage SI, Vilekar P, Donald Weaver (2019). Nutrients in Alzheimer's Disease: The Interaction of Diet, Drugs and Disease . The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques.

Vilekar P, Rao G, Awasthi S, Awasthi V (2015). Diphenyldifluoroketone EF24 Suppresses Pro-inflammatory Interleukin-1 receptor 1 and Toll-like Receptor 4 in lipopolysaccharide-stimulated dendritic cells . Journal of inflammation (London, England).

Yadav VR, Vilekar P, Awasthi S, Awasthi V (2014). Hemorrhage-induced interleukin-1 receptor pathway in lung is suppressed by 3,5-bis(2-fluorobenzylidene)-4-piperidone in a rat model of hypovolemic shock . Artificial organs.

Vilekar P, King C, Lagisetty P, Awasthi V, Awasthi S (2014). Antibacterial activity of synthetic curcumin derivatives: 3,5-bis(benzylidene)-4-piperidone (EF24) and EF24-dimer linked via diethylenetriaminepentacetic acid (EF2DTPA) . Applied biochemistry and biotechnology.

Vilekar P, Awasthi S, Natarajan A, Anant S, Awasthi V (2012). EF24 suppresses maturation and inflammatory response in dendritic cells . International immunology.

Vilekar P, Awasthi V, Lagisetty P, King C, Shankar N, Awasthi S (2010). In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine . BMC immunology.

Lagisetty P, Vilekar P, Sahoo K, Anant S, Awasthi V (2010). CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones . Bioorganic & medicinal chemistry.

Lagisetty P, Vilekar P, Awasthi V (2009). Synthesis of radiolabeled cytarabine conjugates . Bioorganic & medicinal chemistry letters.